Context: Polyherbal drugs in traditional medicine have been time-tested for treatment of a wide variety of chronic ailments. Aims: To determine constituent components in an in-house designed polyherbal formulation GSTC3 and evaluation of consistency in preparation. Settings and Design: In this study, a hypolipidemic formulation was created using well known plant extracts such as Commiphora mukul (Hook. ex Stocks.) Eng. (Burseraceae), Salacia reticulata Wight (Celastraceae), Terminalia arjuna (Roxb.) Wight and Arn (Combretaceae) and Curcuma longa Linn (Zingiberaceae).
SUMMARY
• GSTC is an anti-atherosclerotic polyherbal formulation developed from four individual medicinal plants.
• Powder microscopic analysis of the individual components of GSTC3 served as an authentication of source plant.
• Phytochemical screening ascertained the presence of steroids, terpenoids and polyphenols in the formulation.
• HPTLC analysis of three different batches of GSTC3 ensured stability and integrity among batch to batch preparations.
• Physicochemical analysis showed the feasibility of GSTC3 in its further development as an efficient anti-atherosclerotic drug candidate.
INTRODUCTION
The knowledge passed down through centuries has been time-tested and hence forth priceless. The most prominent examples being traditional systems of medicine such as Ayurveda, Unani and that of the Chinese. Even with the advent of scientific approach for treatment of diseases, traditional systems of medicine especially those related to natural sources such as medicinal plants play a deep-rooted role in modern lifestyles.
With the ever-increasing use of such herbal medicines and resulting expansion of the herbal medicines market, safety has become a major concern for both health authorities and the general public itself. 1 To ratify this predicament, modern scientific approaches may be employed to ensure safety standards while ensuring maximum biological efficacy in the production and marketing of such proprietary medicines. For example, detailed quality requirements for herbal medicinal products on the European market are mentioned in the pharmaceutical legislation of the European Union (EU). 2 As medicinal herbs and herbal formulations are generally considered to be safer than the conventional drugs, traditional systems of medicine or plant-based drugs are attractive and economical alternative treatments because of their professed efficacy in curing diseases. 3 Herbal prescriptions are however most frequently given to patients as complex formulations containing multiple herbs. Unwittingly, this approach amounts to the administration of several chemical entities at once; the underlying theory being that interactions among the chemicals present in different herbs in a formula exert synergistic pharmacodynamic actions and neutralize the adverse effects and toxicities of specific individual chemicals. 4 In such an attempt to develop an anti-atherosclerotic drug candidate, three different polyherbal formulations were prepared consisting of different proportions of extracts of Commiphora mukul (Hook. ex Stocks.) Eng. (Burseraceae) resin, Salacia reticulata Wight (Celastraceae) root, Terminalia arjuna (Roxb.) Wight and Arn (Combretaceae) bark and Curcuma longa Linn (Zingiberaceae) rhizome. The selection of individual plants and preparation of the extracts were based on their scientifically proven efficacy in reducing the risks associated with atherosclerosis. [5] [6] [7] [8] The active components and their modes of actions have also been reJeksy Jos Manalil, Indu Muraleedharan Suseela, Smitha Koyickalmadhom Ramavarma, Arunaksharan Narayanankutty and Achuthan Chathrattil Raghavamenon ported. [9] [10] [11] [12] The individual plant powders of the formulation and the formulation itself in different proportions were tested using various in vitro and in vivo models and are found to have antioxidant, antithrombotic, anti-inflammatory and anti-lipidemic efficacy. The standardisation of the most active formulation GSTC3 was then the next step to be done together with testing for uniqueness in batch to batch preparation. In India, the ayurvedic pharmacopeia (API) records various parameters to be checked in the preparation and use of such products. 13 Here such a study is being undertaken to characterize the polyherbal formulation GSTC3.
SUBJECTS AND METHODS

Source of plant materials
Gum resin of Commiphora mukul, root of Salacia reticulata, bark of Terminalia arjuna and rhizome of Curcuma longa were obtained from the Preparation Unit of Amala Ayurvedic Hospital and Research Centre, Thrissur, Kerala. They were authenticated by the Botanical Survey of India (BSI) using herbarium sheets and voucher specimens were maintained with the BSI Sp. Nos: 77360, 61127, 43886 and 63180, respectively at the herbarium of Amala Ayurvedic Research Centre.
Preparation of plant materials for pharmacognosy
Fresh plant materials were washed under running tap water, air dried, pulverized to fine powder and stored in airtight bottles with proper labelling for future use.
Powder microscopy
The powder characteristics of all four plant constituents were carried out. The slides were prepared using a small portion of each sample mounted in 50% glycerine and were observed under a microscope.
Physicochemical evaluations
Determination of loss on drying About 10 g of drug (without preliminary drying) after accurate weighing was taken in a tarred evaporating dish. This was subjected to drying at 105 0 C for 5 h and weighed again. The drying and weighing process was continued for 1 hour intervals until difference between two successive weighing corresponds to not more than 0.25%.
Determination of total ash
About 2 to 3 g accurately weighed, ground drug was incinerated in a tarred platinum or silica dish at room temperature not exceeding 450 0 C until free from carbon and then cooled and weighed. The percentage of ash with reference to the air-dried drug was calculated.
Determination of acid insoluble ash
The ash obtained in the earlier process was boiled for 5 minutes with 25 mL of dilute hydrochloric acid. The insoluble matter was collected in a gooch crucible, boiled, dried and weighed. The percentage of acidinsoluble ash with reference to the air dried drug was calculated.
Determination of water soluble and alcohol soluble extractives Around 5 g of the air dried drug was macerated, coarsely powdered and kept in 100 mL of water or alcohol for determination of water or alcohol soluble extractives respectively, in a closed flask for twenty-four hours, shaking frequently during six hours and allowed to stand for eighteen hours. After filtering rapidly, taking precautions against loss of solvent, 25 mL of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, and dried at 105 0 C, to constant weight and weighed.
Phytochemical screening 14, 15 Test for steroids and triterpenoids Liebermann Burchard test: The formulation was mixed with few drops of acetic anhydride, boiled and cooled. Concentrated sulphuric acid was then added from the sides of the test tube and observed for formation of a brown ring at the junction of two layers. Green colouration of the upper layer indicate steroids and the formation of deep red colour in the lower layer indicate a positive test for triterpenoids.
Test for cardiac glycosides
Keller Killiani Test: Test solution was treated with few drops of glacial acetic acid and a drop of ferric chloride solution was added and mixed. Concentrated sulphuric acid was added slowly and observed for the formation of two layers. A brown ring at the interface indicated the presence of deoxysugar molecules characteristic of cardenolides. Test for saponins Foam test: Test solution was mixed with water and shaken and observed for the formation of froth, which is stable for 15 minutes giving a positive result. Test for flavonoids Ferric chloride test: Test solution when treated with few drops of ferric chloride solution would result in the formation of blackish red colour indicating flavonoids.
Alkaline reagent test:
Test solution when treated with sodium hydroxide solution, shows increase in the intensity of yellow colour which would become colourless on addition of few drops of dilute hydrochloric acid, indicating the presence of flavonoids.
Test for carbohydrates
Benedict's test: Test solution was mixed with few drops of Benedict's reagent (alkaline solution containing cupric citrate complex) and boiled in water bath, observed for the formation of reddish brown precipitate to show a positive result for the presence of carbohydrate.
Test for alkaloids
Hager's test: Test solution was treated with few drops of saturated picric acid solution. Formation of yellow precipitate indicates presence of alkaloids.
HPTLC Fingerprinting
Each plant extract was prepared as described by previous literature that gave a scientific basis for medicinal activity. Accordingly, C. mukul resin was extracted using petroleum ether, 16 S. reticulata root using water, 17 bark of T. arjuna 18 and rhizome of C. longa using methanol. 19 Approximately, 20 g of each powder was extracted with 150 mL of respective solvent using a magnetic stirrer for 72 h; changing solvent every 24 h. Each time the supernatants obtained by centrifugation were collected. Finally the supernatants were pooled, concentrated and evaporated to dryness in a water bath. Individual solvent free extracts were stored separately in air-tight bottles and kept below 4 0 C. For preparation of GSTC3, preselected weights of the solvent free extract were taken; S. reticulata was dissolved in water while the others were dissolved in propylene glycol for phytochemical analysis and methanol for HPTLC analysis. Samples from three different batches of GSTC3 preparations were applied on to Aluminum backed pre-coated Merck silica gel plate 60 F 254 plate (10×10 cm) using Camag automatic TLC sampler 4 attached to Camag HPTLC system. Approximately 3 μL each of all test solutions were loaded in the form of bands with bandwidth of 8 mm using Hamilton syringe (100 µL). The plate was developed in a solvent system, Toluene: Ethyl acetate: formic acid (7:3:0.2) using a twin trough chamber upto a distance of 9 cm. After the run, the plate was observed under UV light at 254 nm and 366 nm. The R f value and color of the resolved bands were recorded. Densitometric scanning of the plates at 254 nm and 366 nm was done by using Camag TLC scanner 3.
RESULTS
Powder microscopy
Microscopic analysis of Commiphora mukul, showed the presence of resin ducts and oil cells (Figure 1a) . Salacia reticulata on analysis showed presence of cortical parenchymatous cells with starch grains, stone cells and pitted stone cells (Figure 1b) . Terminalia arjuna powder showed the presence of tannin cells, stone cells and fibers (Figure 1c) . Curcuma longa also showed characteristic cork cells, oleo-resin cells, spiral and reticulate vessels (Figure 1 d) .
Physico-chemical parameters
Physico-chemical parameters for purity assessment and standardization of individual plant component were checked according to procedures cited in API. Table 1 shows the physiochemical parameters obtained for the dried powders of individual plant components.
Phytochemical analysis
A variety of biologically active phytochemicals were found to be present in the formulation including phenols, flavonoids, steroids etc. (Table 2) . 
DISCUSSION
The use of herbs has been the mainstay of treatment for a variety of human illnesses and is an essential part of culturally-based healing traditions in many societies and countries. Also, herbs, including Chinese herbs, are being incorporated as remedies for disease management and treatment in Western countries, being regarded as dietary supplements. 20 Standardization of herbal formulations is essential in order to assess quality of drugs, based on the concentration of their active principles, physical, chemical and phytochemical parameters. The quality of herbal formulations is of paramount importance in order to justify their acceptability in modern system of medicine. The physicochemical parameters, quantitative analysis and HPTLC fingerprint profiles together may be used for quality evaluation and the standardization of compound formulations at the primary stage. The poly herbal formulation GSTC3 is a reddish yellow suspension made up of extracts from gum resin of Commiphora mukul, root bark of Salacia reticulata, bark of Terminalia arjuna and rhizome of Curcuma longa. Oleo gum resin extracted from the Commiphora mukul tree is a very complex mixture of gum, minerals, essential oils, terpenes, sterols, ferrulates, flavanones and sterones. Its active constituents, the Z-and Eguggulsterones, have been demonstrated to exhibit their biological activities by binding to nuclear receptors and modulating the expression of proteins involved in carcinogenic activities. 21 The powder microscopic analysis reveals the presence of resin ducts and oil cells which when compared to the API classification is typical of C. mukul. This authenticates the plant sample used. Physiochemical standards were minimum to the standard values described in the API. This indicates the grade of the Phytochemical screening of Terminalia arjuna has shown the active compounds present in high concentration to be phytosterols, lactones, flavonoids, phenolic compounds, tannins and glycosides. 18 Major polyphenolic phytochemicals including curcumin have been isolated from the rhizome of the plant Curcuma longa (turmeric) that has been traditionally used for the treatment of inflammation for centuries. 23 Most of these reported phytochemicals in individual plant components have showed their presence in GSTC3. Even though not quantitatively determined, the presence of active principles in the combined formulation suggests the possibility that an additive/synergetic action of these active principles would be exhibited by GSTC3. Batch to batch preparation of this polyherbal formulation is found to be consistent as revealed by the HTPLC results. In our earlier studies GSTC3 have been found to be a good antioxidant and ant-inflammatory agent, both in vitro and in vivo. 24 The anti-atherosclerotic potential of the formulation has also been demonstrated through its efficacy in preventing serum oxidation, platelet peroxidation and hypolipidemic activity in high fat-diet fed rats with lethal dose 50 (LD 50 ) being above 5 g/kg bwt. 25 Based on these anti-atherosclerotic activities and its nontoxic nature, as well as the fact that both the individual components and the prepared formulation maintain the API standards, GSTC3 could prove to be a fruitful drug candidate against atherosclerosis. The consistency in batch to batch preparation of GSTC3 suggests its unique preparation.
